The search strategy was designed using a combination of Medical Subject Headings (MeSH) and free-text terms relevant to SGLT-2 inhibitors, GLP-1 receptor agonists, and Type 2 Diabetes Mellitus. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.